Biocon Limited ( ($IN:BIOCON) ) has issued an update. Biocon Limited has significantly increased its stake in its unlisted material subsidiary, ...
This capital raise caps off a year of increasing strategic activity for Biocon. Following shareholder approval on December 31, 2025, the company has ramped up steps to consolidate its biosimilars unit ...